Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Lincoln Pharmaceuticals Ltd
Other Long-Term Assets
Lincoln Pharmaceuticals Ltd
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
|
Other Long-Term Assets
₹36.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
226%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Other Long-Term Assets
₹18.6B
|
CAGR 3-Years
24%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Other Long-Term Assets
₹8.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
19%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Other Long-Term Assets
₹46.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Other Long-Term Assets
₹6.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Other Long-Term Assets
₹1.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lincoln Pharmaceuticals Ltd
Glance View
Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm offers products, such as tablets, capsules, liquid injection, cream in tubes, dry power injection, liquid in bott, liquid injection and pharma products. The company has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The firm serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The firm's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.
See Also
What is Lincoln Pharmaceuticals Ltd's Other Long-Term Assets?
Other Long-Term Assets
36.9m
INR
Based on the financial report for Dec 31, 2024, Lincoln Pharmaceuticals Ltd's Other Long-Term Assets amounts to 36.9m INR.
What is Lincoln Pharmaceuticals Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
226%
Over the last year, the Other Long-Term Assets growth was 38%. The average annual Other Long-Term Assets growth rates for Lincoln Pharmaceuticals Ltd have been -1% over the past three years , 226% over the past five years .
You don't have any saved screeners yet